Answers are grounded in this paper and cite their sources.
SUMMARY Despite the advent of new detection techniques for viral pathogens, which has markedly decreased the risk of infectious transmission and increased safety, transfusions are strongly associated with immunosuppression in the host. The best described immunomodulatory effect of blood administration is the increased acceptance and prolonged survival of renal allografts in previously transfused patients. Such transfusion‐related immunomodulation may lead to bacterial infections, increased growth and dissemination of tumor cells, and viral reactivation. This review discusses the known clinical immunomodulatory consequences of transfusion, reviews relevant animal studies and immunologic mechanisms, including the effects of older, stored blood, with special emphasis on the injured patient. In addition, possible strategies to ameliorate transfusion‐related immunomodulation are examined with particular emphasis on prestorage leukoreduction and the use of fresh or washed cellular components.
No takes yet. Share an insight, caveat, or question.
Christopher C. Silliman (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: